Vinpocetine reduces cerebral infarction and edema in I/R injury, and reduces apoptosis, inflammation, and oxidative stress induced by I/R injury via activation of the PI3K/AKT-mediated connexin43 phosphorylation pathway (111). The gene discussed is AKT1; the disease is cerebral infarction.